Delivery Order SPE2DB20D1100-SPE2DB24FB4S6
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp. is a delivery order valued at $1,958.48 for the supply of the pharmaceutical product Wegovy, a 0.25 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 12, 2024. The contract is a firm fixed-price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,326.97 and is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed price contract with an ultimate completion date of March 12, 2025. AmerisourceBergen is the prime contractor, and the contract is not designated as a set-aside. The contract is...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $11,165.72 firm fixed-price delivery order is for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml, with a performance period ending on July 10, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product Wegovy 1.7 mg/0.75 ml pen 0.75 ml. The contract has a ceiling value of $10,165.02 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this...
- This federal contract award is a delivery order worth $5,381.53 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of Wegovy 1 mg/0.5 ml pen 0.5 ml, with a completion date of June 17, 2025. The contract has a firm fixed price pricing type and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,787.18, is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside and was awarded on April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,950.68, is for the delivery of Wegovy 1.7 mg/0.75 ml pens. This is a firm fixed-price delivery order contract with a completion date of February 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Wegovy 0.5 mg/0.5 mL pens. The $21,941.60 firm fixed price delivery order has a period of performance through May 1, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $4,196.43 award is for the supply of the prescription drug Wegovy 2.4 mg/0.75 ml pen with a performance period through March 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, potentially valued at up to $999,999,999.00 through December 31,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award ceiling value of $2,214.88 and is a delivery order for the pharmaceutical product Wegovy 1 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB4S6Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The award, valued at $1,097.08, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen 0.5 ml. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/25/24 |